Not exact matches
Moores Cancer Center is one of the first in the nation recognized by the Quality
Oncology Practice Initiative certification program for
meeting its rigorous standards for high - quality cancer care.
As part of our coverage of the 2017 American Society of Clinical
Oncology (ASCO) Annual
Meeting, held June 2 — 6 in Chicago, we are speaking with Gordon Mills, MD, PhD, chair of the department of systems biology and professor of medicine and immunology at the University of Texas MD Anderson Cancer Center in Houston, about ways to incorporate homologous recombination markers into clinical
practice for ovarian cancer.
Dr. Karen Reckamp talks about ways to incorporate biomarkers for the treatment of lung cancer with immunotherapy into clinical
practice at the 2017 American Society of Clinical
Oncology Annual
Meeting, held June 2 — 6 in Chicago.
Both the ovarian and prostate cancer trials could change clinical
practice, with more women taking the drug bevacizumab (Avastin) to combat the disease in its advanced stages and more men getting radiation therapy for locally advanced prostate cancer, according to researchers who presented the findings Sunday at the American Society of Clinical
Oncology (ASCO) annual
meeting in Chicago.